Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $961.84, giving the company a market capitalization of 910.54B. It carries a P/E multiple of 34.68 and pays a dividend yield of 64.7%.
On 2026-05-03, Eli Lilly(LLY) stock traded between a low of $938.00 and a high of $984.45. Shares are currently priced at $961.84, which is +2.5% above the low and -2.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 4.35M, compared to an average daily volume of 3.7M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
Eli Lilly's supercomputer, developed with Nvidia. Lilly Eli Lilly LLY 3.07 %increase; green up pointing triangle Chief Executive Dave Ricks was on stage with N...
Eli Lilly and Company reported past first-quarter 2026 results with sales of US$19.80 billion and net income of US$7.40 billion, sharply higher than a year earl...
Technology There's Another Twist In The Obesity Pills Showdown — And This One Actually Helps Lilly Licensing The prescription data collected for Eli Lilly's (LL...
Analyst ratings
85%
of 33 ratingsMore LLY News
Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,344 from $1,327 and keeps an Overweight rating on the shares. The firm sees Eli Lilly’s Q...
The drugmaker reported adjusted earnings of $8.55 per share, topping analyst estimates of $6.66, while revenue rose to $19.79 billion versus expectations of $17...
Fueling The ‘Love Affair’ Eli Lilly's revenue skyrocketed 56% year-over-year to $19.8 billion during its first-quarter 2026, driven primarily by the astronomica...
Earnings Call Insights Lilly projects 2026 revenue of $82B-$85B and non-GAAP EPS of $35.50-$37 as Foundayo launch begins Apr 30, 2026, 3:12 PM ET Eli Lilly and...
Early prescription data for Foundayo showed the pill was having a lackluster rollout compared to its competitor. Going into its Thursday morning earnings repor...
Earnings Overview Shows Strong Growth Eli Lilly reported first-quarter adjusted earnings of $8.55 per share, beating the consensus of $6.66. The company’s sales...
Shares in drugmakers Eli Lilly (LLY) and Novo Nordisk (NVO) climbed on Thursday morning after the U.S. health watchdog proposed not to allow outsourcing facilit...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.